The active components and potential mechanisms of Li-Chong-Xiao-Zhen granules in the treatment of ovarian cancer: An integrated metabolomics, proteomics, network pharmacology and experimental validation
Journal of Ethnopharmacology · 2025
DOI: 10.1016/j.jep.2025.119474 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2025. Verfasst von Yiliu Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Traditional Chinese Medicine, Jinan University, 510632, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Drugs, Chinese Herbal. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Fundamental Research Funds for the Central Universities, Traditional Chinese Medicine Bureau of Guangdong Province.
Abstract (Originalsprache)
ETHNOPHARMACOLOGICAL RELEVANCE: Li-Chong-Xiao-Zhen granules (LCXZG) has the effect of " activate blood and resolve stasis," " soften hardness and dissipate binds " properties, and was widely used in the clinic for decades to treat uterine fibroids and ovarian cancer (OC), which is called "zheng jia" in traditional Chinese medicine. AIM OF THE STUDY: The aim of this study is to identify the active components of LCXZG and elucidate the mechanism of LCXZG in ovarian cancer by combining network pharmacology, metabolomics and proteomics. MATERIAL AND METHODS: The absorbed compounds in serum of LCXZG was identified by liquid chromatography-mass spectrometry. Network pharmacology was used to predict the active components and target genes of LCXZG. The therapy mechanism of LCXZG on OC were determined by establishing a nude mouse xenograft tumor model and using combined metabolomics and proteomics analysis. RESULTS: A total of 218 absorbed compounds in serum of LCXZG were identified by UPLC-MS. Network pharmacology results showed that lipid and atherosclerosis, chemical carcinoma-receptor activation and PI3K-AKT signaling were potential target pathways of LCXZG in the treatment of OC. Further metabolomics and proteomics studies demonstrated that LCXZG altered glycerophospholipid metabolism in ovarian cancer. CONCLUSIONS: This study demonstrated that most of the active Compound of LCXZG are Paeoniflorin, Turanose, Amygdalin and Benzoylpaeoniflorin, which may exert their anti-tumor effects by regulating glycerophospholipid metabolism in ovarian cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Traditional Chinese Medicine, Jinan University, 510632, Guangzhou, Guangdong, China.
- Guangdong Yi-fang Pharmaceutical Co. Ltd, Jinan University, 528200, Foshan, Guangdong, China.
- The First Affiliated Hospital of Jinan University, 510632, Guangzhou, Guangdong, China. Electronic address: fwf2000ok@jnu.edu.cn.
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- Fundamental Research Funds for the Central Universities
- Traditional Chinese Medicine Bureau of Guangdong Province
- Guangzhou Municipal Science and Technology Project
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Chen, Y., Su, R., Hu, Y., Luo, J., Yi, C., Zhu, Y., Feng, Q., Yan, X., Ma, M., & Feng, W. (2025). The active components and potential mechanisms of Li-Chong-Xiao-Zhen granules in the treatment of ovarian cancer: An integrated metabolomics, proteomics, network pharmacology and experimental validation. Journal of Ethnopharmacology. https://doi.org/10.1016/j.jep.2025.119474
Vancouver
Chen Y, Su R, Hu Y, Luo J, Yi C, Zhu Y, et al. The active components and potential mechanisms of Li-Chong-Xiao-Zhen granules in the treatment of ovarian cancer: An integrated metabolomics, proteomics, network pharmacology and experimental validation. Journal of Ethnopharmacology. 2025. doi:10.1016/j.jep.2025.119474
BibTeX
@article{Chen2025,
author = {Chen, Yiliu and Su, Ran and Hu, Yunguang and Luo, Jiali and Yi, Chu and Zhu, Yinbin and Feng, Qing and Yan, Xianxin and Ma, Min and Feng, Weifeng},
title = {The active components and potential mechanisms of Li-Chong-Xiao-Zhen granules in the treatment of ovarian cancer: An integrated metabolomics, proteomics, network pharmacology and experimental validation},
journal = {Journal of Ethnopharmacology},
year = {2025},
doi = {10.1016/j.jep.2025.119474}
}
EUVIMED